Sign in

You're signed outSign in or to get full access.

Rajiv Vinnakota

Director at ESAB
Board

About Rajiv Vinnakota

Independent director at ESAB since 2022 (age 54), Vinnakota serves as Chair of the Nominating and Corporate Governance Committee and is a member of the Compensation and Human Capital Management Committee . He is President of the Institute for Citizens & Scholars (since July 2019), with prior executive roles at the Aspen Institute and co‑founder/CEO of The SEED Foundation; he also has long-standing governance experience including service as a trustee of Princeton University and leadership in alumni giving . His ESAB tenure aligns with a phased de‑classification toward annual director elections in 2026 and the Board affirms his independence under NYSE standards .

Past Roles

OrganizationRoleTenureCommittees/Impact
Institute for Citizens & ScholarsPresidentJul 2019–present Leads mission on developing citizens; broad leadership and organizational management
Aspen InstituteExecutive Vice President, Youth & Engagement2015–Sep 2018 Strategic leadership across youth and civic engagement
The SEED FoundationCo‑Founder & CEO; Chairman of Board1997–2015; Chair 1997–2006 Built non‑profit educational model; governance and human capital focus
Mercer Management ConsultingAssociatePrior to SEED Strategy/consulting experience
Princeton UniversityTrustee; Executive Committee; National Chair of Annual GivingTrustee 2004–2007; Exec Comm 2006–2007; Chair 2007–2009 University governance and fundraising leadership

External Roles

OrganizationRoleTenureCommittees/Positions
Enovis Corporation (ENOV)DirectorMay 2008–present Chair, Nominating & Corporate Governance; Member, Compensation & Human Capital Management

Board Governance

  • Committee assignments: Chair, Nominating & Corporate Governance Committee; Member, Compensation & Human Capital Management Committee .
  • Nominating & Corporate Governance met six times in 2024; members: Vinnakota (Chair), Allender, Jordan; all members independent .
  • Compensation & Human Capital Management met six times in 2024; members: Jordan (Chair), Phillipps, Vinnakota; all members independent; uses FW Cook as independent compensation consultant (since 2022) .
  • Independence: Board determined in Feb 2025 that Vinnakota is independent under NYSE standards; executive sessions of independent directors held at least twice per year .
  • Attendance: Board held eight meetings in 2024; each director attended at least 75% of aggregate Board and committee meetings during their service; all directors attended the 2024 annual meeting .
  • Board evaluation: Annual self‑assessments led by the Nominating Chair (Vinnakota), with structured December–February review and actionable follow‑ups .
  • Governance policies: Anti‑hedging/anti‑pledging; rigorous stock ownership requirements for directors; transition to annual elections by 2026 .

Fixed Compensation

ComponentStructure2024 ESAB Director ProgramVinnakota 2024 Amount
Cash retainerPaid quarterlyAnnual cash retainer increased from $90,000 to $95,000 effective Q2 2024 $108,750 (cash fees earned)
Committee chair feePaid quarterly$15,000 for Chairs of Compensation or Nominating & Corporate Governance; $22,500 for Audit Chair Included in cash total as Nominating Chair
Equity award (annual)50% RSUs (1‑yr vest); 50% stock options (fully vested; 7‑yr term)Annual equity grant value increased from $145,000 to $150,000 effective Q2 2024 $75,000 (RSUs grant date fair value) ; $75,000 (options grant date fair value)
Director Deferred Compensation PlanOptional DSUs election in lieu of cash/RSUsDSUs convert to shares after board service; dividends payable on DSUs No DSU election disclosed for Vinnakota in 2024

Notes: RSUs from the 2024 annual grant vest after one year; options are fully vested upon grant and exercisable for seven years . The annual cash/equity changes were effective beginning Q2 2024, contributing to minor prorating in 2024 cash totals .

Performance Compensation

Directors do not have performance‑conditioned equity; grants are time‑ and option‑based to align interests without operational targets .

InstrumentGrant detailsVesting/TermQuantity
RSUs (annual)2024 annual grant on May 9, 2024 Vests one year post‑grant (May 9, 2025) 703 RSUs
Stock Options (annual)2024 annual grantFully vested upon grant; 7‑year term 1,976 options granted in 2024
Outstanding director awards (12/31/2024)Aggregate unvested RSUs and unexercised optionsSee quantities703 RSUs; 17,405 options outstanding

Other Directorships & Interlocks

CompanySector relevanceRelationship to ESABNotes
Enovis CorporationFormer parent; diversified industrial/medtechPre‑spin connection; independent directorServes as Chair, Nominating & Corporate Governance; member, Compensation at Enovis

Compensation Committee Interlocks at ESAB: None—no member has interlocking relationships requiring disclosure under SEC rules .

Expertise & Qualifications

  • Human capital management, organizational leadership, and innovation; public company board experience .
  • Non‑profit sector engagement provides perspective on public policy and societal/economic issues; extensive governance experience across non‑profit boards and committees .
  • Skills matrix for ESAB Board cites human capital/talent management and organizational management among strengths; diverse board composition and experience base .

Equity Ownership

MetricValue
Beneficial ownership (as of Mar 18, 2025)24,007 shares
Shares outstanding (for % calc)60,622,272
Ownership % of outstanding~0.040% (24,007 ÷ 60,622,272)
Unvested RSUs (12/31/2024)703
Stock options outstanding (12/31/2024)17,405
Options exercisable/vesting within 60 days (as of Mar 18, 2025)15,278
Anti‑hedging/anti‑pledging statusHedging and new pledging prohibited; no pledged shares by directors/executives
Director ownership guideline5× annual cash retainer; compliance within five years; all directors in compliance or grace period

Governance Assessment

  • Strengths: Clear independence; active leadership as Nominating Chair with robust board evaluation process; strong committee structures and meeting cadence (Board: 8; Nominating: 6; Compensation: 6); comprehensive anti‑hedging/anti‑pledging and ownership policies; use of independent compensation consultant (FW Cook) with 2025 independence affirmation .
  • Alignment: Director equity grants (RSUs/options) support alignment; ownership building via RSUs/options and guideline of 5× cash retainer; no DSU deferral elected in 2024 (transparent cash/equity mix) .
  • Shareholder signals: Strong Say‑on‑Pay support (98% in 2024), indicating investor confidence in compensation governance, though directed at NEOs .
  • Potential watch items: Dual directorship at Enovis (former parent) is disclosed; ESAB affirms independence and has related‑party review policies with no transactions involving Vinnakota reported .
  • RED FLAGS: None disclosed—no related‑party transactions, no hedging/pledging, no committee interlocks, and attendance thresholds met .